Jul. 16 at 8:55 PM
$TGTX Grok research for advertising push
The increased frequency of TGTX’s TV commercials for BRIUMVI is consistent with pharmaceutical marketing to boost awareness or counter competition, though it’s likely a strategic push rather than a typical "new drug" launch, given the 2022 approval. A conservative estimate for a quarterly TV ad campaign (50 ads/week at
$5,000 per ad) is
$3.5–
$4 million, including ~
$250,000 in production costs for a 30-second ad (amortized over the campaign). A more aggressive campaign (100–200 ads/week) could cost
$7–
$15 million, with production costs included. For precise figures, TGTX’s investor reports or ad tracking services would be needed. Let me know if you want deeper analysis!